SECsense Logo

BioLife Solutions 8-K Report: Key Insights & Compliance Update

$BLFS
Form 8-K
Filed on: 2025-01-13
Source
BioLife Solutions 8-K Report: Key Insights & Compliance Update

Here’s an analysis of the provided section of the financial report:

Key Information Extracted:

  1. Entity Information:
  • Company Name: BioLife Solutions, Inc.
  • CIK (Central Index Key): 0000834365
  • Stock Ticker: BLFS
  • Exchange: NASDAQ
  • Par Value of Common Stock: $0.001 per share
  • Incorporation State: Delaware (DE)
  1. Contact Information:
  • Address: 3303 Monte Villa Parkway, Bothell, WA 98021
  • Phone Number: 425-402-1400
  1. Filing Information:
  • Form Type: 8-K
  • Filing Date: January 13, 2025
  1. Reporting Period:
  • Start Date: January 8, 2024
  • End Date: January 8, 2024
  1. Regulatory References:
  • Schema Reference: blfs-20250113.xsd
  • XBRL Namespace: The report adheres to the XBRL standards for regulatory filings.

Insights:

  • The report is classified as an 8-K filing, typically used to report significant events that shareholders should know about. The specific details regarding the event are not provided in the excerpt.
  • The reporting period is a single day (January 8, 2024), which may indicate a specific event or transaction that occurred on that date, necessitating the filing of this form.
  • The company operates in the biotech sector, as suggested by its name, which could imply focus areas like life sciences or medical solutions.
  • The inclusion of the CIK number signifies compliance with SEC regulations, ensuring the filing is recognized within the SEC’s database.

This summary highlights the essential details and context of the financial report, making it easier for stakeholders to understand the company's current standing and regulatory compliance.